#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arteriosclerosis B-cell lymphoma recurrent Skin cancer Meningitis meningococcal Splenic marginal zone lymphoma Infection in an immunocompromised host Polycythaemia vera Myotonic dystrophy Peritoneal mesothelioma malignant Palmoplantar pustulosis Cholangitis sclerosing Cystic fibrosis gastrointestinal disease Adrenogenital syndrome Friedreich's ataxia Squamous cell carcinoma of the oral cavity More trials…

    Learn about Rare Diseases

    Castleman’s disease – Trials in Disease Vascular malformation – Treatment Primary immunodeficiency syndrome Prader-Willi syndrome – Diagnostics Waldenstrom’s macroglobulinaemia – Treatment Medulloblastoma – Trials in Disease Carcinoid syndrome – Life with Disease Hairy cell leukaemia – Life with Disease Haemophilia A without inhibitors – Basic Information Primary biliary cholangitis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ranitidine Famotidine Betaxolol Pf-06480605 Axatilimab APROTININ Gs-1427 Ademetionine Stx-241 Linagliptin ALE.P03 VANADIUM OXIDE SULFATE Mitapivat Oric-114 Tinengotinib Ptc518 Dl-Alpha Tocopherol Acetate Autologous Pancreatic Islets Felzartamab Bp1.7881A More therapies…

    Learn about Your Condition

    Becker's muscular dystrophy Burning mouth syndrome Diabetic foot infection Still's disease Muscular dystrophy Myopia Conjunctivitis Neuromuscular scoliosis Extraskeletal ossification Prader-Willi syndrome Bacteraemia Aplasia pure red cell Hypertrophic cardiomyopathy Erdheim-Chester disease Spinal cord injury cervical More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer

  • Study Comparing Niraparib and Platinum-Taxane Drug Combination for Patients with Advanced Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Homologous recombination deficiency positive advanced ovarian cancer
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Niraparib Tosilate Monohydrate
    • Carboplatin
    Spain

  • Study of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    France Italy The Netherlands Poland Spain

  • Study of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Farletuzumab Ecteribulin
    • Paclitaxel
    Belgium Italy Spain

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Transitional cell cancer of the renal pelvis and ureter
    • Malignant melanoma
    Investigated Drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain

  • Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +6

  • Study of alpelisib and olaparib combination compared to chemotherapy in patients with platinum-resistant high-grade serous ovarian cancer without BRCA mutation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Alpelisib
    • Doxorubicin Hydrochloride
    • Olaparib
    Finland Germany Spain
Previous Page
1 … 11 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!